Dr. Sheikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2207 S. Clear Creek Rd
Killeen, TX 76549Phone+1 254-200-3200
Summary
- Dr. Ayesha Sheikh is a hematologist and medical oncologist in Central Texas. She has 5 board certifications from ABIM including internal medicine, hematology, oncology, geriatrics and hospice and palliative medicine. She has special interest in providing a holistic, multidimensional care to all her patients especially older adults with a goal of prolonging life while maintaining quality of life
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Harvard Macy InstituteCertification, A systems approach to assessment in health professions education, 2017 - 2017- Boston University Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2016 - 2017
- SkillpathCertification, Leadership and management skills for women, 2016 - 2016
Brown UniversityResidency, Internal Medicine, 2006 - 2009
Allama Iqbal Medical CollegeClass of 2003
Certifications & Licensure
TX State Medical License 2022 - 2026
MA State Medical License 2009 - 2023
RI State Medical License 2006 - 2009- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Gold medal MBBS Punjab University, 2002
Publications & Presentations
PubMed
- 6 citationsPrognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer.David Cheng, Clark Dumontier, Ayesha R Sheikh, Jennifer La, Mary T Brophy
Cancer Medicine. 2022-08-01 - 110 citationsCK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic TargetMelissa Chua, Charina E. Ortega, Ayesha Rizwan Sheikh, Migi Lee, Hussein Abdul-Rassoul
Pharmaceuticals. 2017-01-28 - 3 citationsThe impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer.Camille V Edwards, Ayesha R Sheikh, Michael J Dennis, Andrew Hunter, Zoe P Mackay
Journal of Thoracic Disease. 2022-10-01
Journal Articles
- Perspectives on Geriatric Oncology Research Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual MeetingAyesha Sheikh, Tina Hsu, Ishwariah Subbiah, Sukeshi Arora, JGO, 2019
- CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic TargetMelissa Chua, Ayesha Sheikh, Kevan Hartshorn, Isabel Dominguez, Pharmaceuticals, 1/28/2017
Abstracts/Posters
- “Evaluation of an electronic frailty index (eFI) as a significant predictor of survival in U.S. Veterans with newly diagnosed non-small cell lung cancer (NSCLC)"Ayesha Sheikh, David Cheng, Nathaniel Filmore, David Tuck, ASCO 2019 annual meeting, Chicago, 6/3/2019
- Improving Pneumococcal 13-valent Conjugate (PCV13) Vaccination Rates and Physician Documentation in the Geriatrics ClinicAyesha Sheikh, Sarah Phillips, Vassiliki Pravodelov, Stephanie Scott, John McCahan Medical Campus Education Day, BU Medical School, Boston, 5/31/2017
- Improving Pneumococcal 13-valent Conjugate (PCV13) Vaccination Rates and Physician Documentation in the Geriatrics ClinicAyesha Sheikh, Sarah Phillips, Vassiliki Pravodelov, Stephanie Scott, AGS annual meeting, San Antonio, Texas, 5/21/2017
Lectures
- Predictive value of an electronic frailty index (FI) in U.S. Veterans with newly diagnosed non-small cell lung cancer (NSCLC).2019 ASCO Annual Meeting - 6/1/2019
- Effectiveness and safety of Apixaban vs. Warfarin in non-valvular Atrial fibrillation in real world clinical practiceGeriatrics Journal Club - 4/7/2017
- Direct Oral Anticoagulants - PracticalitiesEdith Nourse Rogers Memorial VA Medical Center - 3/31/2017
- Join now to see all
Research History
- Exploring unexpected inpatient mortality in cancer patients – root cause analysis2019 - Present
- Substance Use Disorders and Cancer Outcomes in Patients with Non-Small Cell Lung Cancer2018 - Present
- Massachusetts Veterans and Epidemiology Research and Information 10/2018 - Present(A) Evaluation of an electronic frailty index (eFI) as a significant predictor of survival in U.S. Veterans with newly diagnosed non-small cell lung cancer (NSCLC) (B) Evaluation of an eFI as a predictor of chemotherapy toxicity and acute care hospitalization in patients diagnosed with NSCLC2018 - Present
Professional Memberships
- Member
- Fellow
- Member
- Member
- Member
- Member
Other Languages
- Urdu, Punjabi, Hindi
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
